Purpose of the T-Force Gold Study.

Purpose of the T-Force Gold Study.

The primary purpose of this clinical research study is to determine the safety, tolerability, and effectiveness of an investigational medication for Tourette syndrome in children. An investigational medication is one that is not approved by the US Food and Drug Administration (FDA).

Who may qualify.

Who may qualify.

The T-Force Gold Study may be appropriate for those who meet the following criteria:

  • Boys and girls aged 6–17 years
  • Have a diagnosis of Tourette syndrome and symptoms that impair school, occupational, and/or social function
  • Are in good general health, as determined by medical history, physical examination, and laboratory tests

Study schedule.

Study schedule.

Participants in the T-Force Gold Study will need to:

  • Attend a Screening Visit to determine eligibility
  • Participate in the clinical research study for up to 18 weeks, including up to nine visits at a local study site
  • Receive a total of 12 weeks of daily study drug dosing
  • After completing 12 weeks of study drug dosing, attend all follow-up visits required by the study physician